Vanguard Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $29.8M | Sell |
|
|||||
|
2025
Q1 | $40.4M | Buy |
|
|||||
|
2024
Q4 | $26.3M | Sell |
|
|||||
|
2024
Q3 | $41.6M | Sell |
|
|||||
|
2024
Q2 | $69.7M | Buy |
|
|||||
|
2024
Q1 | $108M | Buy |
|
|||||
|
2023
Q4 | $115M | Buy |
|
|||||
|
2023
Q3 | $107M | Buy |
|
|||||
|
2023
Q2 | $237M | Buy |
|
|||||
|
2023
Q1 | $209M | Buy |
|
|||||
|
2022
Q4 | $186M | Buy |
|
|||||
|
2022
Q3 | $187M | Buy |
|
|||||
|
2022
Q2 | $153M | Buy |
|
|||||
|
2022
Q1 | $153M | Buy |
|
|||||
|
2021
Q4 | $195M | Sell |
|
|||||
|
2021
Q3 | $214M | Buy |
|
|||||
|
2021
Q2 | $274M | Buy |
|
|||||
|
2021
Q1 | $356M | Buy |
|
|||||
|
2020
Q4 | $398M | Buy |
|
|||||
|
2020
Q3 | $276M | Sell |
|
|||||
|
2020
Q2 | $197M | Sell |
|
|||||
|
2020
Q1 | $139M | Buy |
|
|||||
|
2019
Q4 | $339M | Buy |
|
|||||
|
2019
Q3 | $652M | Buy |
|
|||||
|
2019
Q2 | $843M | Buy |
|
|||||
|
2019
Q1 | $726M | Buy |
|
|||||
|
2018
Q4 | $385M | Sell |
|
|||||
|
2018
Q3 | $577M | Buy |
|
|||||
|
2018
Q2 | $598M | Buy |
|
|||||
|
2018
Q1 | $606M | Buy |
|
|||||
|
2017
Q4 | $552M | Buy |
|
|||||
|
2017
Q3 | $176M | Buy |
|
|||||
|
2017
Q2 | $219M | Buy |
|
|||||
|
2017
Q1 | $191M | Buy |
|
|||||
|
2016
Q4 | $124M | Buy |
|
|||||
|
2016
Q3 | $106M | Buy |
|
|||||
|
2016
Q2 | $52.5M | Buy |
|
|||||
|
2016
Q1 | $52M | Buy |
|
|||||
|
2015
Q4 | $77.7M | Buy |
|
|||||
|
2015
Q3 | $47.9M | Buy |
|
|||||
|
2015
Q2 | $62.8M | Buy |
|
|||||
|
2015
Q1 | $31.3M | Buy |
|
|||||
|
2014
Q4 | $8.15M | Buy |
|
|||||
|
2014
Q3 | $1.02M | Buy |
|